Literature DB >> 6502165

Cortisol production during high dose dexamethasone therapy in neurological and neurosurgical patients.

T Brophy, J B Chalk, K Ridgeway, J H Tyrer, M J Eadie.   

Abstract

Simultaneous plasma dexamethasone and cortisol levels were followed at intervals over 8 hour periods on 40 occasions in 19 subjects who received regular high dosage dexamethasone therapy (rarely less than 12 mg a day) for various neurological and neurosurgical conditions. Lower dexamethasone doses (for example 2 mg daily for 2 days) normally suppress adrenal cortical production of cortisol to below 50 micrograms/l for at least 8 hours. However, in 12 of the 35 studies that did not take place at the first steroid dose or in subjects taking second daily bolus steroid dosage such suppression was not present 8 to 12 hours after dexamethasone intake, though it was shown that dexamethasone could suppress cortisol production in all these cases. Failure of maintained suppression despite the high steroid dose appeared to be related to rapid elimination of dexamethasone. These findings may help explain the relative rarity of adrenal failure in clinical neurological practice after high dosage steroid therapy is ceased.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6502165      PMCID: PMC1028037          DOI: 10.1136/jnnp.47.10.1081

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  5 in total

1.  Effect of diphenylhydantoin on the metabolism of dexamethasone.

Authors:  W Jubiz; A W Meikle; R A Levinson; S Mizutani; C D West; F H Tyler
Journal:  N Engl J Med       Date:  1970-07-02       Impact factor: 91.245

2.  Nonlinear least-squares regression programs for microcomputers.

Authors:  C C Peck; B B Barrett
Journal:  J Pharmacokinet Biopharm       Date:  1979-10

3.  Dexamethasone suppression tests: usefulness of simultaneous measurement of plasma cortisol and dexamethasone.

Authors:  A W Meikle
Journal:  Clin Endocrinol (Oxf)       Date:  1982-04       Impact factor: 3.478

Review 4.  The dexamethasone suppression test in depression.

Authors:  H S Green; J M Kane
Journal:  Clin Neuropharmacol       Date:  1983-03       Impact factor: 1.592

5.  High performance liquid chromatographic assay of dexamethasone in plasma and tissue.

Authors:  B E Cham; B Sadowski; J M O'Hagan; C N de Wytt; F Bochner; M J Eadie
Journal:  Ther Drug Monit       Date:  1980       Impact factor: 3.681

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.